for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Exelon Corporation

EXC.O

Latest Trade

47.73USD

Change

-0.22(-0.46%)

Volume

4,801,223

Today's Range

47.55

 - 

48.17

52 Week Range

43.41

 - 

51.18

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
47.95
Open
47.85
Volume
4,801,223
3M AVG Volume
129.21
Today's High
48.17
Today's Low
47.55
52 Week High
51.18
52 Week Low
43.41
Shares Out (MIL)
972.00
Market Cap (MIL)
46,398.76
Forward P/E
--
Dividend (Yield %)
3.04

Next Event

Q4 2019 Exelon Corp Earnings Release

Latest Developments

More

Exelon Generation To Begin Negotiations To Acquire RE Ginna, Nine Mile Point And Calvert Cliffs

Exelon Reports Q3 Earnings Per Share $0.79

Agera Energy Files Chapter 11 Protection, Enters Into Agreement To Sell Its Retail Assets To Constellation

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Exelon Corporation

Exelon Corporation is a utility services holding company. The Company, through its subsidiary, Exelon Generation Company, LLC (Generation), is engaged in the energy generation business. The Company, through its subsidiaries, Commonwealth Edison Company (ComEd), PECO Energy Company (PECO), Baltimore Gas and Electric Company (BGE), Pepco Holdings LLC (PHI), Potomac Electric Power Company (Pepco), Delmarva Power & Light Company (DPL) and Atlantic City Electric Company (ACE), is engaged in the energy delivery businesses. It operates through 12 segments: Generation's six segments: Mid-Atlantic, Midwest, New England, New York, ERCOT and Other Power Regions; ComEd; PECO; BGE, and PHI's three utility segments: Pepco, DPL and ACE. Generation's integrated business consists of the generation, physical delivery and marketing of power across geographical regions through its customer-facing business, Constellation, which sells electricity and natural gas to both wholesale and retail customers.

Contact Info

PO Box 805398

+1.312.3947399

http://www.exeloncorp.com/

Executive Leadership

Mayo Adams Shattuck

Independent Chairman of the Board

Christopher M. Crane

President, Chief Executive Officer, Director

Joseph Dominguez

Chief Executive Officer, ComEd

Joseph Nigro

Senior Executive Vice President and Chief Financial Officer

Michael A. Innocenzo

President and Chief Executive Officer, PECO

Key Stats

2.06 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

31.9K

2017

33.5K

2018

36.0K

2019(E)

34.1K
EPS (USD)

2016

2.680

2017

2.600

2018

3.120

2019(E)

3.117
Price To Earnings (TTM)
20.06
Price To Sales (TTM)
1.33
Price To Book (MRQ)
1.45
Price To Cash Flow (TTM)
5.55
Total Debt To Equity (MRQ)
117.77
LT Debt To Equity (MRQ)
101.32
Return on Investment (TTM)
2.35
Return on Equity (TTM)
2.07

Latest News

Latest News

BRIEF-Breckenridge Announces Final Approval Of Its ANDA For Rivastigmine Transdermal System (Generic For Exelon Patch)

* BRECKENRIDGE PHARMACEUTICAL - U.S. FDA GRANTED FINAL APPROVAL FOR ITS ANDA FOR RIVASTIGMINE TRANSDERMAL SYSTEM (GENERIC FOR EXELON PATCH BY NOVARTIS) Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up